Publications by authors named "Laura Gallur"

Claim this Profile
E
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells.
Gloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, Ana Á Martín-López, Mi Kwon, Laura Gallur

Hemasphere· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Cristina A Tentori, Lin P Zhao, Benedetta Tinterri, Kathryn E Strange, Katharina Zoldan, Laura Gallur

Hemasphere· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
Gloria Iacoboni, Víctor Navarro, Ana África Martín-López, Kai Rejeski, Mi Kwon, Laura Gallur

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL.
Viktoria Blumenberg, Galina Busch, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Laura Gallur

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocytes-Rich Thrombi in Cerebral Large Vessel Occlusion Are Associated with Increased Stiffness and Poorer Revascularization Outcomes.
Jesús Juega, Jiahui Li, Carlos Palacio-Garcia, Maite Rodriguez, Riccardo Tiberi, Laura Gallur

Neurotherapeutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte-to-Lymphocyte Ratio in Clot Analysis as a Marker of Cardioembolic Stroke Etiology.
Jesús Juega, Carlos Palacio-Garcia, Maite Rodriguez, Matias Deck, David Rodriguez-Luna, Laura Gallur

Transl Stroke Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant t(11;22)(q13;q11.2) with involvement in mantle cell lymphoma.
Alba Cabirta, Gloria Hidalgo-Gómez, Ana Marín-Niebla, Laura Gallur, Silvia Saumell

Leuk Lymphoma· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes.
Sílvia Saumell, Miranda Fernández-Serrano, Alba Mesa, Félix López-Cadenas, Leonor Arenillas, Laura Gallur

Leuk Lymphoma· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is acute lymphoblastic leukemia with mature B-cell phenotype and rearrangements a new entity? A systematic review and meta-analysis.
Gloria Hidalgo-Gómez, Carlos Palacio-Garcia, Laura Gallur, Adoración Blanco, Bárbara Tazón-Vega

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy.
Juan C Nieto, Elisa Roldán, Isabel Jiménez, Laura Fox, Júlia Carabia, Laura Gallur

Leukemia· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes.
Julia Montoro, Helena Pomares, Guillermo Villacampa, Brayan Merchán, Antonieta Molero, Laura Gallur

Leuk Lymphoma· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes.
Julia Montoro, Laura Gallur, Brayan Merchán, Antonieta Molero, Elisa Roldán

Ann Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
Noelia Purroy, Juan Bergua, Laura Gallur, Julio Prieto, Luis A Lopez

Br J Haematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
Francisco Javier Peñalver, Alberto Alvarez-Larrán, Jose Luis Díez-Martin, Laura Gallur, Isidro Jarque

Ann Hematol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia.
Izaskun Elorza, Carlos Palacio, Jose Luis Dapena, Laura Gallur, José Sánchez de Toledo

Haematologica· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
Francisco Javier Peñalver, Victor Jiménez-Yuste, Manuel Almagro, Alberto Alvarez-Larrán, Lluis Rodríguez, Laura Gallur

Ann Hematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis